CTAP
SIGMA/C6352 - ≥95%
CAS Number: 103429-32-9
Empirical Formula (Hill Notation): C51H69N13O11S2
Molecular Weight: 1104.30
MDL Number: MFCD00671434
Linear Formula: C51H69N13O11S2
Product Type: Chemical
| assay | ≥95% |
| form | powder |
| InChI | 1S/C51H69N13O11S2/c1-26(6 |
| InChI key | OFMQLVRLOGHAJI-FGHAYEPSSA |
| Quality Level | 200 ![]() |
| SMILES string | C[C@@H](O)[C@H](NC(=O)[C@ |
| storage temp. | −20°C |
| UniProt accession no. | Q62923 ![]() |
| Amino Acid Sequence: | D-Phe-Cys-Tyr-D-Trp-Arg-T |
| Application: | CTAP has been used as a μ-opioid receptor (MOR) antagonist: • to study the anti-hyperalgesic effect of dipeptidyl peptidase 4 (DPP4) inhibitor isoleucine-proline-isoleu • to study the role of MOR in glutamate and gamma-aminobutyric acid (GABA) efflux during predator stress in rats • to determine the endogenous opioid peptide involved in blocking pain induced by activated gastrin-releasing peptide (Grp+) neurons |
| Biochem/physiol Actions: | CTAP is a peptide antagonist produced from somatostatin analogs. |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥95% |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |

